Skip to content

the effect of a 20% mannitol solution and a 10% hypertonic saline solution on increased intracranial pressure after large hemispheric infarction

the effect of a 20% mannitol solution and a 10% hypertonic saline solution on increased intracranial pressure after large hemispheric infarction

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17010545
Enrollment
Unknown
Registered
2017-02-03
Start date
2017-01-26
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

large hemispheric infarction

Interventions

Mannitol Group:mannitol and hypertonic saline
Hypertonic Saline Group:hypertonic saline and mannitol

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 80 years; 2. within 72h of stroke onset; 3. somnolence, or Full Outline of Unresponsiveness Scale=14, or Glasgow Coma Scale=12; 4. receiving no treatments of any other methods to reduce ICP, such as excess ventilation, barbiturate load, hypothermia, decompressive craniectomy, and external ventricular drainage; 5. ischemic signs on CT/MRI involving at least 2/3 of the MCA territory.

Exclusion criteria

Exclusion criteria: 1. both pupils fixed and dilated or anisocoria; 2. congestive heart failure; 3. acute myocardial infarction; 4. shock, systolic blood pressure50mmHg), and cannot be corrected within a short time; 6. kidney failure (Cr>2mg/dL) , and cannot be corrected within a short time; 7. Hypoproteinemia (ALB160mmol/L, or K+5.0mmol/L, or plasma osmotic pressure>340 mOsm/L), and cannot be corrected within a short time; 9. pregnancy or postpartum perioperative period; 10. local infection at insertion site; 11. patients with coagulopathy (PLT1.3).

Design outcomes

Primary

MeasureTime frame
intracranial pressure;pupil;

Countries

China

Contacts

Public ContactSu Yingying

Xuanwu Hospital, Capital Medical University

tangsuyingying@sina.com+86 15699959572

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026